December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy? ↗
Via The Motley Fool
Topics Lawsuit
Tickers HIMS NVO
Exposures Financial Legal Product Safety
News headline image
QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 ↗
Via Stocktwits
Tickers IBB QURE RY SBIO TSX:RY WFC
Exposures Product Safety
News headline image
ImmunityBio Announces FDA Resubmission For Expanded Use Of Lead Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
QURE DEADLINE: Investors of uniQure N.V. (QURE) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on April 13, 2026
Via NewMediaWire
Topics Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
Loyalty Gamification Guide: How to Increase Engagement in 2026
Via BusinesNews Wire
Topics Product Recall
Exposures Legal Product Safety
News headline image
QURE DEADLINE: Investors of uniQure N.V. (QURE) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on April 13, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
New Year, Same Ford Problem: But Investors Shouldn't Panic ↗
Via The Motley Fool
Topics Product Recall
Tickers F
Exposures Legal Product Safety
News headline image
The Pivot to Legitimacy: Hims & Hers Health (HIMS) Faces a New Era of Personalized Medicine
Via Finterra
Topics Artificial Intelligence Economy
Tickers AMZN HIMS LLY
Exposures Artificial Intelligence Product Safety Supply Chain
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT
Exposures Intellectual Property Product Safety
News headline image
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy ↗
Via Stocktwits
Topics Intellectual Property Lawsuit
Tickers AVDE HIMS NVO PPH PVAL
Exposures Financial Intellectual Property Legal
News headline image
IBRX Stock Declines Pre-Market — ImmunityBio Resubmits Anktiva Application To FDA With Additional Data ↗
Via Stocktwits
Tickers IBRX IWM VB XBI
Exposures Product Safety
News headline image
OS Therapies Announces FDA OST-HER2 Type D Meeting Elevated to Type B Pre-BLA Meeting
Via Newsfile
Topics Intellectual Property
Tickers OSTX
Exposures Intellectual Property Product Safety
News headline image
Can IBRX Stock Snap Its 4-Day Slide? Founder Promises ‘Game-Changer’ Anktiva Data As FDA Speeds Drug Reviews ↗
Via Stocktwits
Tickers IBRX
Exposures Product Safety
News headline image
uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP; April 13, 2026, Lead Plaintiff Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP; April 13, 2026, Lead Plaintiff Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy? ↗
Via The Motley Fool
Topics Death
Tickers NTLA
Exposures Death Product Safety
News headline image
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox Before April 21, 2026
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox Before April 21, 2026
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Bristol Myers Wins FDA Approval for Sotyktu for Psoriatic Arthritis ↗
Via Benzinga
Exposures Product Safety
News headline image
Why Ford Stock Sank This Week ↗
Via The Motley Fool
Topics Product Recall
Tickers F
Exposures Legal Product Safety
News headline image
CORT ALERT: Deadline in Securities Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT) is April 21, 2026 - Contact Kaplan Fox
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
CORT ALERT: Deadline in Securities Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT) is April 21, 2026 - Contact Kaplan Fox
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Investors of uniQure N.V. (QURE) Seeking Recovery - Contact Kaplan Fox Before Deadline on April 13, 2026
Via NewMediaWire
Topics Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
Investors of uniQure N.V. (QURE) Seeking Recovery - Contact Kaplan Fox Before Deadline on April 13, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
Marco Robinson’s Channel 4 TV Show “Get a House for Free” : Families Share How Their Lives Have Changed
Via BusinesNews Wire
Topics Product Recall
Exposures Legal Product Safety
News headline image
Biotech Stock QURE Once Tagged ‘Failed Product’ — CEO Sold Shares Days Before Rally ↗
Via Stocktwits
Tickers QURE
Exposures Product Safety
News headline image
Controversial FDA Vaccines Chief Vinay Prasad To Leave Agency In April ↗
Via Benzinga
Exposures Product Safety
News headline image
CORCEPT THERAPEUTICS CLASS ACTION DEADLINE: Kaplan Fox Encourages Corcept Therapeutics, Inc. (NASDAQ: CORT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on April 21, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
CORCEPT THERAPEUTICS CLASS ACTION DEADLINE: Kaplan Fox Encourages Corcept Therapeutics, Inc. (NASDAQ: CORT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on April 21, 2026
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Moderna Pops As Vinay Prasad, The FDA's Controversial Vaccine Head, Will Depart In April ↗
Via Investor's Business Daily
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.